Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Evidence-based clinical practice guidelines for liver cirrhosis 2015
H Fukui, H Saito, Y Ueno, H Uto, K Obara… - Journal of …, 2016 - Springer
Abstract The Japanese Society of Gastroenterology revised the evidence-based clinical
practice guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected …
practice guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected …
Refractory ascites in liver cirrhosis
D Adebayo, SF Neong, F Wong - Official journal of the American …, 2019 - journals.lww.com
Ascites, a common complication of liver cirrhosis, eventually becomes refractory to diuretic
therapy and sodium restriction in∼ 10% of patients. Multiple pathogenetic factors are …
therapy and sodium restriction in∼ 10% of patients. Multiple pathogenetic factors are …
[PDF][PDF] Management of adult patients with ascites due to cirrhosis: an update
BA Runyon - Hepatology, 2009 - Wiley Online Library
A Medline search from 1966 through 2007 was performed; search terms included ascites,
hepatorenal syndrome, diet therapy, drug therapy, radiotherapy, surgery, and therapy. The …
hepatorenal syndrome, diet therapy, drug therapy, radiotherapy, surgery, and therapy. The …
[หนังสือ][B] Sherlock's diseases of the liver and biliary system
A new, fully updated edition of the world's most famous book on liver diseases—with
updating of all areas and inclusion of new specific topics, by internationally renowned …
updating of all areas and inclusion of new specific topics, by internationally renowned …
Current management of portal hypertension
AS Wright, LF Rikkers - Journal of gastrointestinal surgery, 2005 - Springer
Portal hypertension can lead to life-threatening hemorrhage, ascites, and encephalopathy.
This paper reviews the pathophysiology and multidisciplinary management of portal …
This paper reviews the pathophysiology and multidisciplinary management of portal …
TIPS with expanded polytetrafluoroethylene–covered stent: Results of an Italian multicenter study
C Vignali, I Bargellini, M Grosso… - American Journal of …, 2005 - ajronline.org
OBJECTIVE. Our objective is to describe the results of a multicenter prospective trial on the
safety and efficacy of transjugular intrahepatic portosystemic shunts (TIPS) using the Viatorr …
safety and efficacy of transjugular intrahepatic portosystemic shunts (TIPS) using the Viatorr …
Fluid retention in cirrhosis: pathophysiology and management
A Kashani, C Landaverde, V Medici… - QJM: An International …, 2008 - academic.oup.com
Accumulation of fluid as ascites is the most common complication of cirrhosis. This is
occurring in about 50% of patients within 10 years of the diagnosis of cirrhosis. It is a …
occurring in about 50% of patients within 10 years of the diagnosis of cirrhosis. It is a …
Current approaches to the management of patients with cirrhotic ascites
DV Garbuzenko, NO Arefyev - World journal of …, 2019 - pmc.ncbi.nlm.nih.gov
This review describes current approaches to the management of patients with cirrhotic
ascites in relation to the severity of its clinical manifestations. The PubMed database, the …
ascites in relation to the severity of its clinical manifestations. The PubMed database, the …
[HTML][HTML] Current treatment options of refractory ascites in liver cirrhosis–a systematic review and meta-analysis
Background Refractory ascites is a severe complication of liver cirrhosis and treatment
options consist in large volume paracentesis, transjugular intrahepatic portosystemic shunt …
options consist in large volume paracentesis, transjugular intrahepatic portosystemic shunt …
ePTFE‐TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis
T Bucsics, S Hoffman, J Grünberger… - Liver …, 2018 - Wiley Online Library
Abstract Background & Aims Reduction in portal pressure by self‐expandable
polytetrafluoroethylene (ePTFE)‐covered transjugular intrahepatic portosystemic shunts …
polytetrafluoroethylene (ePTFE)‐covered transjugular intrahepatic portosystemic shunts …